Deferasirox
treatment for a rare or metabolic disease
Nothing to addBy the Layer Nutrition editorial team · How the atlas classifies the 664 molecules
What this medicine is for
Pharmacologically, Deferasirox relates to the category “treatment for a rare or metabolic disease”. This medicine is aimed at a specific rare or metabolic disease, in a specialized setting.
Specifically, for Deferasirox: Removes iron overload caused by transfusions. It is part of specialized, closely monitored care.
Under which brands it is found
Deferasirox is part of the composition of about 8 presentations listed in France. It is found under several brand names and as generics.
- Deferasirox Accord
- Deferasirox Arrow
- Deferasirox Biogaran
- Deferasirox Mylan
- Deferasirox Sandoz
- Deferasirox Teva
- Deferasirox Zentiva
- Exjade
Generics and the original brand are equivalent for the active substance; only the appearance, the name or the excipients may differ.
Do you need a supplement? No.
For Deferasirox, we offer no supplement. No nutritional supplementation has any serious justification to set against this treatment, and we prefer to say so rather than invent a need. Our range is limited to five classes of everyday medicines for which a targeted intake makes sense; beyond these, we sell nothing for the sake of selling, and that is what gives weight to our five references.
Related molecules
To explore in the « Other areas » family and its neighbours.